Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04214990 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients

Study acronym: EASTERN
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 31, 2027 to Mar 31, 2031
    • Study sites: 11 to 10
    • Study completion date: Dec 31, 2028 to Mar 31, 2032
    • Collaborators: 10 to 12
    v6
  2. Re-verified, no change to tracked fieldsv5
  3. Study sites: 9 to 11
    • Eligibility criteria expanded, about 30 words
    • Collaborators: 8 to 10
    • Study description expanded, about 4 words
    v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 9
    • Start date changed from estimate of Jan 15, 2020 to Feb 15, 2020
    v3
  5. Secondary endpoints: 5 to 6v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aimed to investigate the effect of low-dose (100 mg) asprin on the prevention of gastric cancer in the early gastric cancer patients with negative H. pylori status who underwent endoscopic submucosal dissection.
Trial Details
NCT Number NCT04214990
Lead Sponsor National Cancer Center, Korea
Collaborators: Incheon St.Mary's Hospital/The Catholic University, Kosin University Gospel Hospital, Pusan National University Hospital, SMG-SNU Boramae Medical Center, Chonnam National University Hospital, Chung-Ang University Hospital, Chilgok Kyungpook National University, Hallym University Medical Center, Asan Medical Center, Seoul National University Bundang Hospital, Severance Hospital, Samsung Medical Center
Conditions
(from sponsor)		 Aspirin, Gastric Cancer
Related terms Stomach Neoplasms
Enrollment 1,700 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov